Calidi Biotherapeutics Inc. to Showcase RedTail Platform and Oncology Advancements in Investor Webinar
Calidi Biotherapeutics Inc. (NYSE American: CLDI) will host an investor webinar to discuss its RedTail platform and advancements in oncology, highlighting the potential of its CLD-401 candidate to eliminate tumors and activate immune memory.
